#iDR26 Attendee Resources

Links to key documents


Give feedback

  • We would appreciate it if you could take a few minutes to give your feedback on the event here.

Practical information


In case you missed it

  • Join the ‘Medicines Reimagined’ discussion forum.
  • iDR article in Nature Reviews Drug Discovery: A newly published article in Nature Reviews Drug Discovery, co-authored by members of the iDR26 team. Inspired by discussions at previous International Drug Repurposing Conferences, the article explores how we can make the most of the potential of drug repurposing – from earlier patient involvement and better use of real-world data to stronger validation of AI/ML approaches, clearer regulatory and reimbursement pathways, coordinated funding, and closer collaboration across sectors. The core message? Breaking down silos is key to making drug repurposing the new normal. Read the article here.
  • Help us spread the word about #iDR26 – view and download materials to use to help promote the event.

Need support or guidance with your repurposing project? Submit a request to the Repurposing Concierge.

Looking to fund repurposing research – join the REMEDi4ALL Funders network.

Keep up to date with the latest news from REMEDi4ALL with our Newsletter.

Want to learn more about the drug repurposing process – visit the Digital Academy.

12 & 13 May

2026

Brussels

BELGIUM

Co-organisers

REMEDi4ALL

REMEDi4ALL is an EU-funded research initiative that is driving forward the repurposing of medicines in Europe.

Beacon: For Rare Diseases (BEACON) - United Kingdom
Beacon for rare diseases

Beacon is a UK-based charity that is building a united rare disease community with patient groups at its heart.

Sponsors

Interested in joining this event? Subscribe to the newsletter

We will keep you updated on the event. You can unsubscribe at any time.